Studies in Stereochemistry XIV. Diels-Alder adducts in the resin series; action of peracids and acid-catalysed ring opening of epoxides
SummaryThe synthesis of Diels-Alder compounds of type 2 with a 17-nor-l3(14)-atisbne skeleton is described (cf. Schemes 2-3). Depending on the nature and configuration of substituents R1 and R2 on the carbon atoms 15 and 16, an epoxide (24-33) or a ketone (35-38) or a mixture of epoxide, ketone and lactone is obtained by the action of p-nitroperbenzoic acid on the double bond of these adducts (cf. Scheme 4). A simplified reaction scheme is suggested to explain the formation of the various products. In an acid-catalysed reaction, the epoxides isomerize mainly into ketones. Nevertherless, in some cases, dienes (e.g. 52) or hydroxy-y-lactones of (13R*, 14S*)-configuration (e.g. 50) resulting from the opening of the epoxide ring with retention of configuration were obtained.Les adduits de Diels-Alder prkparks h partir du lkvopimarate de mkthyle (1) ou des rksinates de mkthyle avec divers ditnophiles tthylkniques ont la formule gknkrale 2 (squelette et numkrotation de l'atisane). La double liaison de ces adduits est peu rkactive A cause de facteurs stkriques: ainsi, elle n'est pas hydrogknable par les mk- Partie XIII: [l].
R e~u le 25 mars 1969 L'action de l'anhydride malkique sur les esters rksiniques conduit non seulement ti l'adduit classique 3a mais aussi ti l'exo-anhydro-malkopimarate de methyle (3b) dont la structure est prouvee par des nlesures physiques et des transforn~ations chimiques.
Die Bromolactonisierung einiger Diels‐Alder‐Addukte liefert im basischen oder sauren Medium entgegen den Erwartungen nicht die trans‐ oder cis‐Produkte.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.